Skip to main content

Table 1 The clinical, operative and pathological characteristics between the elderly and nonelderly group before and after propensity score matching

From: Oncological prognosis and morbidity of hepatectomy in elderly patients with hepatocellular carcinoma: a propensity score matching and multicentre study

Characteristics

Before PSM(n = 1331)

P

After PSM(n = 668)

P

Elderly

Nonelderly

Elderly

Nonelderly

n = 363

n = 968

n = 334

n = 334

Age #

70.38 (4.46)

51.55 (8.56)

< 0.001

70.25 (4.47)

52.16 (8.66)

< 0.001

Male sex

298 (82.09)

829 (85.64)

0.130

274 (82.04)

277 (82.93)

0.839

ASA score > 2

124 (34.16)

184 (19.01)

< 0.001

114 (34.13)

68 (20.30)

< 0.001

Overweight

107 (29.48)

337 (34.81)

0.076

97 (29.04)

95 (28.44)

0.932

Comorbidity

177 (48.76)

177 (18.29)

< 0.001

162 (48.50)

49 (14.67)

< 0.001

AFP > 400 µg/l

92 (25.34)

361 (37.29)

< 0.001

91 (27.25)

88 (26.35)

0.861

ALT > 40 U/L

117 (32.23)

404 (41.74)

0.002

115 (34.43)

111 (33.23)

0.806

AST > 40 U/L

163 (44.90)

424 (43.80)

0.765

147 (44.01)

147 (44.01)

0.999

HBV infection

300 (82.64)

859 (88.74)

0.004

283 (84.73)

285 (85.33)

0.914

Cirrhosis

165 (45.45)

432 (44.63)

0.835

148 (44.31)

147 (44.01)

0.999

Portal hypertension

113 (31.13)

374 (38.64)

0.014

108 (32.34)

104 (31.14)

0.803

Child‒Pugh grade B

11 (3.03)

51 (5.27)

0.114

11 (3.29)

10 (2.99)

0.999

BCLC staging B/C

109 (30.03)

364 (37.60)

0.012

98 (29.34)

101 (30.24)

0.866

Intraoperative variables

Open operative approach

283 (77.96)

819 (84.61)

0.005

264 (79.04)

268 (80.24)

0.773

Margin width < 1 cm

63 (17.36)

111 (11.47)

0.006

49 (14.67)

50 (14.97)

0.999

Blood loss > 600ml

29 (7.99)

76 (7.85)

0.999

25 (7.49)

29 (8.68)

0.670

Intraoperative blood transfusion

84 (23.14)

212 (21.90)

0.682

79 (23.65)

85 (25.45)

0.653

Operation duration > 180 min

234 (64.46)

757 (78.20)

< 0.001

226 (67.66)

224 (67.07)

0.934

Anatomical hepatectomy

190 (52.34)

443 (45.76)

0.038

170 (50.90)

166 (49.70)

0.816

Extended hemihepatectomy

56 (15.43)

179 (18.49)

0.220

53 (15.87)

61 (18.26)

0.472

Occlusion

200 (55.10)

543 (56.10)

0.791

183 (54.79)

196 (58.68)

0.349

Tumor variables

Macrovascular invasion

25 (6.89)

105 (10.85)

0.039

24 (7.19)

18 (5.39)

0.425

MVI

110 (30.30)

306 (31.61)

0.695

104 (31.14)

87 (26.05)

0.171

Satellite nodules

34 (9.37)

163 (16.84)

0.001

33 (9.88)

30 (8.98)

0.791

Poor Tumor differentiation

281 (77.41)

629 (64.98)

< 0.001

254 (76.05)

253 (75.75)

0.999

Incomplete tumor envelope

30 (8.26)

168(17.36)

< 0.001

29 (8.68)

30 (8.98)

0.999

Tumor diameter > 5 cm

167 (46.01)

427 (44.11)

0.577

153 (45.81)

142 (42.51)

0.436

  1. Values in parentheses are percentages unless stated otherwise; #values are mean(s.d.). AFP, alpha-fetoprotein; ASA, American Society of Anesthesiologists; ALT, alanine aminotransferase; AST, aspartate transaminase; BCLC, Barcelona Clinic Liver Cancer; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; MVI, microvascular invasion